Your search returned 2 results.

Results
	1.	Baseline autoantibody profiles predict normalization of complement and anti-dsDNA autoantibody levels following rituximab treatment in systemic lupus erythematosus. [electronic resource] by Tew, G W Rabbee, N Wolslegel, K Hsieh, H-J Monroe, J G Behrens, T W Brunetta, P G Keir, M E Producer: 20100325 In: Lupus vol. 19 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)
	2.	Review article: nonclinical and clinical pharmacology, pharmacokinetics and pharmacodynamics of etrolizumab, an anti-β7 integrin therapy for inflammatory bowel disease. [electronic resource] by Tang, M T Keir, M E Erickson, R Stefanich, E G Fuh, F K Ramirez-Montagut, T McBride, J M Danilenko, D M Producer: 20190916 In: Alimentary pharmacology & therapeutics vol. 47 Online resources: Available from publisher's website Availability: No items available. Save to lists Add to cart (remove)

Refine your search